Total Funding
50
56
Total FundingSeries B raised
Growth Score 50 in past quarter
-2 pts
Heat Score 56 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
155790
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
- James Li: Co founder & CEO
About the Company
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based immunotherapies that uses chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to regulate the body's immune system, enabling doctors to
save the lives of cancer patients and improve the quality of life.